Diabetes, Vol 39, Issue 7 865-870, Copyright © 1990 by American Diabetes Association

ARTICLES

Evidence against altered expression of GLUT1 or GLUT4 in skeletal muscle of patients with obesity or NIDDM

O Pedersen, JF Bak, PH Andersen, S Lund, DE Moller, JS Flier and BB Kahn
Division of Endocrinology, University Clinic of Internal Medicine, Aarhus Amtssygehus, Denmark.

Studies of experimental diabetes in rodents induced by the beta-cell toxin streptozocin have shown that the insulin-resistant glucose transport of peripheral tissues (muscle and adipose) in these animals can be ascribed in part to a pretranslational reduction of the major insulin-sensitive glucose transporter (GLUT4) in these tissues. Because a central feature of non-insulin-dependent diabetes mellitus (NIDDM) is an imparied ability of insulin to enhance glucose disposal in skeletal muscle, we examined the hypothesis that reduced expression of GLUT4 is a characteristic finding in the skeletal muscle of subjects with NIDDM. Biopsies of skeletal muscles were obtained from 17 patients with NIDDM and 10 lean and 9 obese nondiabetic subjects. Among the diabetic subjects, 7 were newly diagnosed and untreated. Compared with age-matched and body-weight-matched healthy control subjects, there was no significant alteration in the level of GLUT4 mRNA demonstrated by Northern blot and slot blot or GLUT4 protein determined by immunoblotting muscle membranes. Neither GLUT4 mRNA nor protein concentration correlated with the degree of glycemic control, fasting plasma insulin or glucose, diabetes duration, body mass index, sex, or age. GLUT1 mRNA and protein levels were also not significantly different between diabetic and matched control subjects. Thus, unlike streptozocin-induced diabetes in rodents, there is no evidence that impaired expression of the major insulin-responsive glucose transporter is responsible for insulin-resistant glucose transport in the skeletal muscle of these lean and moderately obese NIDDM patients.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				D. J. Cuthbertson, J. A. Babraj, K. J.W. Mustard, M. C. Towler, K. A. Green, H. Wackerhage, G. P. Leese, K. Baar, M. Thomason-Hughes, C. Sutherland, et al. 5-Aminoimidazole-4-Carboxamide 1-{beta}-D-Ribofuranoside Acutely Stimulates Skeletal Muscle 2-Deoxyglucose Uptake in Healthy Men Diabetes, August 1, 2007; 56(8): 2078 - 2084. [Abstract] [Full Text] [PDF]

				M. Sowers, H. Zheng, K. Tomey, C. Karvonen-Gutierrez, M. Jannausch, X. Li, M. Yosef, and J. Symons Changes in Body Composition in Women over Six Years at Midlife: Ovarian and Chronological Aging J. Clin. Endocrinol. Metab., March 1, 2007; 92(3): 895 - 901. [Abstract] [Full Text] [PDF]

				F. W. Booth and S. J. Lees Fundamental questions about genes, inactivity, and chronic diseases Physiol Genomics, January 17, 2007; 28(2): 146 - 157. [Abstract] [Full Text] [PDF]

				H. Storgaard, P. Poulsen, C. Ling, L. Groop, and A. A. Vaag Genetic and Nongenetic Determinants of Skeletal Muscle Glucose Transporter 4 Messenger Ribonucleic Acid Levels and Insulin Action in Twins J. Clin. Endocrinol. Metab., February 1, 2006; 91(2): 702 - 708. [Abstract] [Full Text] [PDF]

				N. Saravanan, A. Haseeb, N. Z Ehtesham, and Ghafoorunissa Differential effects of dietary saturated and trans-fatty acids on expression of genes associated with insulin sensitivity in rat adipose tissue Eur. J. Endocrinol., July 1, 2005; 153(1): 159 - 165. [Abstract] [Full Text] [PDF]

				D. S. Fernandez-Twinn, A. Wayman, S. Ekizoglou, M. S. Martin, C. N. Hales, and S. E. Ozanne Maternal protein restriction leads to hyperinsulinemia and reduced insulin-signaling protein expression in 21-mo-old female rat offspring Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2005; 288(2): R368 - R373. [Abstract] [Full Text] [PDF]

				T. P. Ciaraldi, S. Mudaliar, A. Barzin, J. A. Macievic, S. V. Edelman, K. S. Park, and R. R. Henry Skeletal Muscle GLUT1 Transporter Protein Expression and Basal Leg Glucose Uptake Are Reduced in Type 2 Diabetes J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 352 - 358. [Abstract] [Full Text] [PDF]

				C. Bouche, S. Serdy, C. R. Kahn, and A. B. Goldfine The Cellular Fate of Glucose and Its Relevance in Type 2 Diabetes Endocr. Rev., October 1, 2004; 25(5): 807 - 830. [Abstract] [Full Text] [PDF]

				M. Rossmeisl, J. S. Rim, R. A. Koza, and L. P. Kozak Variation in Type 2 Diabetes-Related Traits in Mouse Strains Susceptible to Diet-Induced Obesity Diabetes, August 1, 2003; 52(8): 1958 - 1966. [Abstract] [Full Text] [PDF]

				A. Tardif, N. Julien, J.-L. Chiasson, and L. Coderre Stimulation of glucose uptake by chronic vanadate pretreatment in cardiomyocytes requires PI 3-kinase and p38 MAPK activation Am J Physiol Endocrinol Metab, June 1, 2003; 284(6): E1055 - E1064. [Abstract] [Full Text] [PDF]

				W. Derave, B. O. Eijnde, P. Verbessem, M. Ramaekers, M. Van Leemputte, E. A. Richter, and P. Hespel Combined creatine and protein supplementation in conjunction with resistance training promotes muscle GLUT-4 content and glucose tolerance in humans J Appl Physiol, May 1, 2003; 94(5): 1910 - 1916. [Abstract] [Full Text] [PDF]

				H. A. Koistinen, D. Galuska, A. V. Chibalin, J. Yang, J. R. Zierath, G. D. Holman, and H. Wallberg-Henriksson 5-Amino-Imidazole Carboxamide Riboside Increases Glucose Transport and Cell-Surface GLUT4 Content in Skeletal Muscle From Subjects With Type 2 Diabetes Diabetes, May 1, 2003; 52(5): 1066 - 1072. [Abstract] [Full Text] [PDF]

				R. C. Ho, K. P. Davy, M. S. Hickey, S. A. Summers, and C. L. Melby Behavioral, metabolic, and molecular correlates of lower insulin sensitivity in Mexican-Americans Am J Physiol Endocrinol Metab, October 1, 2002; 283(4): E799 - E808. [Abstract] [Full Text] [PDF]

				V. K. Yechoor, M.-E. Patti, R. Saccone, and C. R. Kahn Coordinated patterns of gene expression for substrate and energy metabolism in skeletal muscle of diabetic mice PNAS, August 6, 2002; 99(16): 10587 - 10592. [Abstract] [Full Text] [PDF]

				S. E. Campbell and M. A. Febbraio Effect of the ovarian hormones on GLUT4 expression and contraction-stimulated glucose uptake Am J Physiol Endocrinol Metab, May 1, 2002; 282(5): E1139 - E1146. [Abstract] [Full Text] [PDF]

				A. S. Ryan, B. J. Nicklas, and D. M. Berman Hormone Replacement Therapy, Insulin Sensitivity, and Abdominal Obesity in Postmenopausal Women Diabetes Care, January 1, 2002; 25(1): 127 - 133. [Abstract] [Full Text] [PDF]

				L. Maianu, S. R. Keller, and W. T. Garvey Adipocytes Exhibit Abnormal Subcellular Distribution and Translocation of Vesicles Containing Glucose Transporter 4 and Insulin-Regulated Aminopeptidase in Type 2 Diabetes Mellitus: Implications Regarding Defects in Vesicle Trafficking J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5450 - 5456. [Abstract] [Full Text] [PDF]

				D. S. Hardin, A. Leblanc, G. Marshall, and D. K. Seilheimer Mechanisms of insulin resistance in cystic fibrosis Am J Physiol Endocrinol Metab, November 1, 2001; 281(5): E1022 - E1028. [Abstract] [Full Text] [PDF]

				M. Gaster, P. Staehr, H. Beck-Nielsen, H. D. Schrøder, and A. Handberg GLUT4 Is Reduced in Slow Muscle Fibers of Type 2 Diabetic Patients: Is Insulin Resistance in Type 2 Diabetes a Slow, Type 1 Fiber Disease? Diabetes, June 1, 2001; 50(6): 1324 - 1329. [Abstract] [Full Text]

				M. Gaster, J. Franch, P. Staehr, H. Beck-Nielsen, T. Smith, and H. D. Schroder Induction of GLUT-1 protein in adult human skeletal muscle fibers Am J Physiol Endocrinol Metab, November 1, 2000; 279(5): E1191 - E1195. [Abstract] [Full Text] [PDF]

				M. Gaster, A. Handberg, H. Beck-Nielsen, and H. D. Schroder Glucose transporter expression in human skeletal muscle fibers Am J Physiol Endocrinol Metab, September 1, 2000; 279(3): E529 - E538. [Abstract] [Full Text] [PDF]

				J. Liu, J. A. Knezetic, L. Strömmer, J. Permert, J. Larsson, and T. E. Adrian The Intracellular Mechanism of Insulin Resistance in Pancreatic Cancer Patients J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 1232 - 1238. [Abstract] [Full Text]

				C. Kausch, A. Hamann, I. Uphues, A. Niendorf, D. Müller-Wieland, H.-G. Joost, P. Algenstaedt, M. Dreyer, H. W. Rüdiger, H.-U. Häring, et al. Association of Impaired Phosphatidylinositol 3-Kinase Activity in GLUT1-Containing Vesicles with Malinsertion of Glucose Transporters into the Plasma Membrane of Fibroblasts from a Patient with Severe Insulin Resistance and Clinical Features of Werner Syndrome J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 905 - 918. [Abstract] [Full Text]

				B. F. Holmes, E. J. Kurth-Kraczek, and W. W. Winder Chronic activation of 5'-AMP-activated protein kinase increases GLUT-4, hexokinase, and glycogen in muscle J Appl Physiol, November 1, 1999; 87(5): 1990 - 1995. [Abstract] [Full Text] [PDF]

				N. Hjeltnes, D. Galuska, M. Björnholm, A.-k. Aksnes, A. Lannem, J. R. Zierath, and H. Wallberg-Henriksson Exercise-induced overexpression of key regulatory proteins involved in glucose uptake and metabolism in tetraplegic persons: molecular mechanism for improved glucose homeostasis FASEB J, December 1, 1998; 12(15): 1701 - 1712. [Abstract] [Full Text]

				A. Y. Xing, J. C. Challier, J. Lepercq, M. Caüzac, M. J. Charron, J. Girard, and S. Hauguel-de Mouzon Unexpected Expression of Glucose Transporter 4 in Villous Stromal Cells of Human Placenta J. Clin. Endocrinol. Metab., November 1, 1998; 83(11): 4097 - 4101. [Abstract] [Full Text]

				T. Hayashi, J. F. P. Wojtaszewski, and L. J. Goodyear Exercise regulation of glucose transport in skeletal muscle Am J Physiol Endocrinol Metab, December 1, 1997; 273(6): E1039 - E1051. [Abstract] [Full Text] [PDF]

				E. Tozzo, L. Gnudi, and B. B. Kahn Amelioration of Insulin Resistance in Streptozotocin Diabetic Mice by Transgenic Overexpression of GLUT4 Driven by an Adipose-Specific Promoter Endocrinology, April 1, 1997; 138(4): 1604 - 1611. [Abstract] [Full Text] [PDF]

				M. J. Thomson, M. G. Williams, and S. C. Frost Development of Insulin Resistance in 3T3-L1 Adipocytes J. Biol. Chem., March 21, 1997; 272(12): 7759 - 7764. [Abstract] [Full Text] [PDF]

				J. M. Stephens, J. Lee, and P. F. Pilch Tumor Necrosis Factor-alpha -induced Insulin Resistance in 3T3-L1 Adipocytes Is Accompanied by a Loss of Insulin Receptor Substrate-1 and GLUT4 Expression without a Loss of Insulin Receptor-mediated Signal Transduction J. Biol. Chem., January 10, 1997; 272(2): 971 - 976. [Abstract] [Full Text] [PDF]

				G. Hotamisligil, N. Shargill, and B. Spiegelman Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance Science, January 1, 1993; 259(5091): 87 - 91. [Abstract] [PDF]